Back to
Federation des caisses Desjardins du Quebec
BCTX4 quarters
Position history for
Federation des caisses Desjardins du Quebec's holdings in BRIACELL THERAPEUTICS CORP
Yes. Federation des caisses Desjardins du Quebec holds 450 shares of BCTX (Briacell Therapeutics), worth $1,444, as of its Q2 2026 13F filing. It reduced the position by 5 shares (-1.1%) from Q1 2026. Federation des caisses Desjardins du Quebec has held BCTX since Q3 2025, across 4 quarterly 13F filings.
Current Value
$1,444
Current Shares
450
Total Value Change
-$8,394
Total Shares Change
-455
Quarter-by-Quarter History
Other major holders of BCTX: UBS Group AG, CITADEL ADVISORS LLC, HRT FINANCIAL LP, JANE STREET GROUP, LLC